Introduction. The treatment of the severe forms of photodermatoses often re
quires potent systemic immunosuppressive drugs. We report two patients suff
ering from severe photodermatitis successfully treated with oral ciclospori
ne,
Cases report, A 58-year-old man developed severe pruritic eczematous reacti
ons for several years on light-exposed and light-protected skin following e
ach sun exposure. A 66-year-old man showed similar lesions restricted to th
e head and neck. The clinical presentation and evolution as well as histolo
gic, immunohistologic, allergologic and photobiologic assessments suggested
the diagnosis of actinic reticuloid and persistent light reactivity, respe
ctively. The lesions of both patients did not respond to a high dose regime
n of systemic corticosteroids (methylprednisolone 1 mg/kg/day) for several
weeks. The severity of cutaneous lesions and pruritus required another pote
nt immunosuppressive treatment. Oral ciclosporine at the maximum daily dose
of 4 mg/kg was given for three months. A rapid improvement of the pruritus
and skin lesions occurred in the two patients, without significant side-ef
fect. The first patient experienced reccurrent lesions after termination of
cyclosporine treatment during summer time. The other patient did not devel
op new skin eruption for 3 years after stopping the initial treatment with
ciclosporine.
Discussion, Low-dose oral cyclosporine is a quick-acting and well tolerated
symptomatic treatment of severe photodermatoses resistant to other systemi
c immunosuppressive drugs. However, therapeutic results do not consistently
exhibit long-standing remanent effect.